Efficacy and safety of rilpivirine‐based regimens in treatment‐experienced HIV‐1 infected patients:...
Efficacy and safety of rilpivirine‐based regimens in treatment‐experienced HIV‐1 infected patients: a prospective cohort study
About this item
Full title
Author / Creator
Publisher
Switzerland: International AIDS Society
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: International AIDS Society
Subjects
More information
Scope and Contents
Contents
Introduction
Rilpivirine (RPV) is a new once‐daily, non‐nucleoside, reverse transcriptase inhibitor (NNRTI). In treatment‐naïve patients, RPV has shown non‐inferior antiviral activity to efavirenz but data in treatment‐experienced patients are more limited. We assessed the efficacy and safety of RPV in treatment‐experienced patients switching to...
Alternative Titles
Full title
Efficacy and safety of rilpivirine‐based regimens in treatment‐experienced HIV‐1 infected patients: a prospective cohort study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4225255
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4225255
Other Identifiers
ISSN
1758-2652
E-ISSN
1758-2652
DOI
10.7448/IAS.17.4.19796
